Effects of prostaglandins A1, E1, E2 and F2alpha on the basilar artery of cats. 1974

J Handa, and S Yoneda, and M Matsuda, and H Handa

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002415 Cats The domestic cat, Felis catus, of the carnivore family FELIDAE, comprising over 30 different breeds. The domestic cat is descended primarily from the wild cat of Africa and extreme southwestern Asia. Though probably present in towns in Palestine as long ago as 7000 years, actual domestication occurred in Egypt about 4000 years ago. (From Walker's Mammals of the World, 6th ed, p801) Felis catus,Felis domesticus,Domestic Cats,Felis domestica,Felis sylvestris catus,Cat,Cat, Domestic,Cats, Domestic,Domestic Cat
D003250 Constriction The act of constricting. Clamping,Clampings,Constrictions
D004106 Dilatation The act of dilating. Dilation,Dilatations,Dilations
D005260 Female Females
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations

Related Publications

J Handa, and S Yoneda, and M Matsuda, and H Handa
February 1979, Prostaglandins,
J Handa, and S Yoneda, and M Matsuda, and H Handa
December 1976, Neuropharmacology,
J Handa, and S Yoneda, and M Matsuda, and H Handa
March 1976, British journal of pharmacology,
J Handa, and S Yoneda, and M Matsuda, and H Handa
October 1974, Nature,
J Handa, and S Yoneda, and M Matsuda, and H Handa
September 1975, British journal of pharmacology,
J Handa, and S Yoneda, and M Matsuda, and H Handa
May 1978, The American journal of physiology,
J Handa, and S Yoneda, and M Matsuda, and H Handa
January 1976, Journal of cell science,
J Handa, and S Yoneda, and M Matsuda, and H Handa
September 1973, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
J Handa, and S Yoneda, and M Matsuda, and H Handa
May 1977, The Journal of pharmacy and pharmacology,
J Handa, and S Yoneda, and M Matsuda, and H Handa
May 1974, Pflugers Archiv : European journal of physiology,
Copied contents to your clipboard!